Compare SFHG & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFHG | NXPL |
|---|---|---|
| Founded | 1993 | 1997 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Telecommunications Equipment |
| Sector | Consumer Discretionary | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 19.2M |
| IPO Year | 2024 | N/A |
| Metric | SFHG | NXPL |
|---|---|---|
| Price | $0.71 | $0.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 81.4K | ★ 85.2K |
| Earning Date | 10-30-2025 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $19,577,200.00 | ★ $57,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.56 | N/A |
| 52 Week Low | $0.32 | $0.43 |
| 52 Week High | $1.29 | $1.13 |
| Indicator | SFHG | NXPL |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 55.49 |
| Support Level | $0.65 | $0.68 |
| Resistance Level | $0.78 | $0.72 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 25.32 | 74.97 |
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.